ALBERT JANG
Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology ROCHESTER, MN NPI 1003376468
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology MN PFIZER INC. All categories
General Payments — all program years on this page
$5,149.35
- Category: General Payments
- Program years: PY2021–2024
- Record count: 103
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,855.67 across 64 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,655.69 | 62 |
| Education | $199.98 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $439.62 | 7 |
| Takeda Pharmaceuticals U.S.A., Inc. | $424.16 | 7 |
| Acerta Pharma LLC | $380.00 | 6 |
| Daiichi Sankyo Inc. | $211.58 | 4 |
| Merck Sharp & Dohme Corporation | $182.94 | 4 |
| EISAI INC. | $147.87 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $129.69 | 6 |
| Amgen Inc. | $129.11 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $118.30 | 1 |
| Janssen Biotech, Inc. | $100.44 | 1 |
| GlaxoSmithKline, LLC. | $89.27 | 1 |
| Incyte Corporation | $75.52 | 4 |
| Tempus AI, Inc | $69.70 | 1 |
| Astellas Pharma US Inc | $55.82 | 2 |
| ABBVIE INC. | $52.79 | 2 |
| GENZYME CORPORATION | $52.47 | 2 |
| AVEO Pharmaceuticals, Inc. | $46.97 | 2 |
| Celgene Corporation | $33.19 | 2 |
| SOBI, INC | $22.02 | 1 |
| JAZZ PHARMACEUTICALS INC. | $21.78 | 1 |
| Gilead Sciences, Inc. | $19.98 | 1 |
| Blueprint Medicines Corporation | $19.81 | 1 |
| Genmab U.S., Inc. | $19.22 | 1 |
| Verity Pharmaceuticals Inc. | $13.42 | 1 |
By program year
Records — PY2024 (64)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.